Jane Huang
CIK 1683913 · View on SEC EDGAR ↗
First SEC filing: June 16, 2026 · Latest: June 16, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 4, 2018 | ONC | S 10b5-1 | 2,911 | $174.60 | $508,261 | 0 Direct | -100.00% | Disposed | 113.5% (price as of 2026-08-20) |
| Dec. 21, 2017 | ONC | S | 1,000 | $98.00 | $98,000 | 0 Direct | -100.00% | Disposed | 280.4% (price as of 2026-08-20) |
| Dec. 13, 2017 | ONC | S | 200 | $94.53 | $18,906 | 0 Direct | -100.00% | Disposed | 294.4% (price as of 2026-08-20) |
| Dec. 13, 2017 | ONC | S | 1,300 | $94.21 | $122,473 | 200 Direct | -86.67% | Disposed | 295.7% (price as of 2026-08-20) |
| Dec. 4, 2017 | ONC | S 10b5-1 | 1,100 | $86.00 | $94,600 | 0 Indirect | -100.00% | Disposed | 333.5% (price as of 2026-08-20) |
| Nov. 20, 2017 | ONC | S 10b5-1 | 1,000 | $87.00 | $87,000 | 1,100 Indirect | -47.62% | Disposed | 328.5% (price as of 2026-08-20) |
| Nov. 16, 2017 | ONC | S 10b5-1 | 600 | $85.00 | $51,000 | 2,100 Indirect | -22.22% | Disposed | 338.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 15, 2026 | TARA | Stock Option (Right to Buy) | Common Stock (31,000) | $3.94 | June 14, 2036 | 31,000 | Acquired |
| June 12, 2025 | TARA | Stock Option (Right to Buy) | Common Stock (24,000) | $3.26 | June 11, 2035 | 24,000 | Acquired |
| June 7, 2024 | TARA | Stock Option (Right to Buy) | Common Stock (10,000) | $2.67 | June 6, 2034 | 10,000 | Acquired |
| July 4, 2023 | PRLD | Restricted Stock Unit | Common Stock (9,375) | — | — | 9,375 | Disposed |
| June 7, 2023 | TARA | Stock Option (Right to Buy) | Common Stock (10,000) | $2.85 | June 6, 2033 | 10,000 | Acquired |
| June 8, 2022 | TARA | Stock Option (Right to Buy) | Common Stock (10,000) | $3.50 | June 7, 2032 | 10,000 | Acquired |
| May 2, 2022 | PRLD | Restricted Stock Unit | Common Stock (150,000) | — | — | 150,000 | Acquired |
| May 2, 2022 | PRLD | Employee Stock Option (Right to Buy) | Common Stock (460,000) | $4.86 | April 30, 2032 | 460,000 | Acquired |
| June 9, 2021 | TARA | Stock Option (Right to Buy) | Common Stock (20,000) | $10.51 | June 8, 2031 | 20,000 | Acquired |
| June 9, 2021 | TARA | Stock Option (Right to Buy) | Common Stock (10,000) | $10.51 | June 8, 2031 | 10,000 | Acquired |
| June 26, 2018 | ONC | Share Option (Right to Buy) | Ordinary Shares | — | June 25, 2028 | 310,180 | Acquired |
| Dec. 21, 2017 | ONC | Share Option (Right to Buy) | Ordinary Shares (1,367,500) | — | Sept. 2, 2026 | 13,000 | Disposed |
| Dec. 13, 2017 | ONC | Share Option (Right to Buy) | Ordinary Shares (1,380,500) | — | Sept. 2, 2026 | 19,500 | Disposed |
| June 27, 2017 | ONC | Share Option (Right to Buy) | Ordinary Shares | — | June 26, 2027 | 980,465 | Acquired |
| Sept. 2, 2016 | ONC | Share Option (Right to Buy) | Ordinary Shares (1,400,000) | $2.27 | Sept. 2, 2016 | 1,400,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ONC
Former Chief MedicalOfficer,Hematology(16)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $460,000 | — | — | — | $295,550 | — | $12,525 | $5,117,775 |
| 2020 | $443,333 | — | — | — | $294,813 | — | $11,400 | $3,349,395 |
| 2019 | $435,000 | — | — | $2,319,972 | $262,088 | — | $8,400 | $3,605,347 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $568,333 | — | — | — | $264,550 | — | $10,350 | $1,438,904 |
| 2023 | $545,833 | — | — | — | $316,250 | — | $3,546 | $1,654,662 |
| 2022 | $391,761 | $4,450 | — | — | $167,344 | — | — | $2,920,215 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.